Single and combined deletions of the NTAL/LAB and LAT adaptors minimally affect B-cell development and function

被引:40
|
作者
Wang, Y
Horvath, O
Hamm-Baarke, A
Richelme, M
Grégoire, C
Guinamard, R
Horejsi, V
Angelisova, P
Spicka, J
Schraven, B
Malissen, B
Malissen, M
机构
[1] Univ Mediterranee, CNRS, INSERM, Ctr Immunol Marseille Luminy, F-13288 Marseille, France
[2] Acad Sci Czech Republ, Inst Mol Genet, Prague 14220 4, Czech Republic
[3] Univ Magdeburg, Inst Immunol, D-39120 Magdeburg, Germany
关键词
D O I
10.1128/MCB.25.11.4455-4465.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
NTAL (non-T-cell activation linker, also called LAB) and LAT (linker for activation of T cells) are evolutionarily related transmembrane adaptor proteins that are phosphorylated upon immunoreceptor engagement. Using quantitative reverse transcription-PCR, both NTAL and LAT were found to be expressed in B cells. However, LAT expression was limited to early B cells, whereas NTAL expression typified mature B cells. To delineate their roles in B-cell development and function, Ntal-deficient mice were generated and crossed with Lat-deficient mice. B cells developed in Lat(-/-) Ntal(-/-) double-deficient mice and in mice lacking either of the two adaptors with the same efficiency as in wild-type mice. Upon B-cell antigen receptor cross-linking, Ntal(-1-) B cells exhibited slightly increased Ca2+ mobilization and proliferation. In addition, Ntal-deficient mice had increased levels of natural antibodies and slightly increased Immoral response to a T-dependent antigen. Normal titers of serum-specific immunoglobulins were produced in response to a T-cell-independent antigen. Although NTAL is also expressed in plasma cells, its absence did not affect the hypergammaglobulinemia E and G1 that developed in mice with a mutation in tyrosine 136 of LAT. Therefore, NTAL does not play a role in B cells symmetric to the role played by LAT in T cells.
引用
收藏
页码:4455 / 4465
页数:11
相关论文
共 50 条
  • [31] RB TRANSCRIPTIONAL COREPRESSOR 1 (RB1) GENE DELETIONS ADVERSELY AFFECT THE OUTCOME IN PEDIATRIC B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Gupta, Sanjeev Kumar
    Bakhshi, Sameer
    Gupta, Ritu
    Sharma, Preity
    Gajendra, Smeeta
    Leons, Gadha
    Pushpam, Deepam
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [32] Development and validation of a combined cuproptosis and immunogenic cell death prognostic model for diffuse large B-cell lymphoma
    Wang, Nana
    Shi, Shanshan
    Li, Moran
    Yu, Xiaoning
    Ma, Guangxin
    AGING-US, 2024, 16 (02): : 1218 - 1236
  • [33] Analysis of intrinsic defects of B-cell function in X-linked severe combined immunodeficiency.
    White, H
    Thrasher, AJ
    Veys, PA
    Kinnon, C
    Gaspar, HB
    BLOOD, 1999, 94 (10) : 617A - 617A
  • [34] THE STATUS OF IG LOCI REARRANGEMENTS IN SINGLE CELLS FROM DIFFERENT STAGES OF B-CELL DEVELOPMENT
    TENBOEKEL, E
    MELCHERS, F
    ROLINK, A
    INTERNATIONAL IMMUNOLOGY, 1995, 7 (06) : 1013 - 1019
  • [35] Development of the antibody repertoire as revealed by single-cell PCR of FACS-sorted B-cell subsets
    Kantor, AB
    Merrill, CE
    MacKenzie, JD
    Herzenberg, LA
    Hillson, JL
    IMMUNOGLOBULIN GENE EXPRESSION IN DEVELOPMENT AND DISEASE, 1995, 764 : 224 - 227
  • [36] Development and Characterization of a Novel Single-Chain Antibody Against B-Cell Activating Factor
    Mardani-Jouneghani, Rasoul
    Irani, Shiva
    Habibi-Anbouhi, Mahdi
    Behdani, Mahdi
    MOLECULAR BIOTECHNOLOGY, 2023, 65 (12) : 1968 - 1978
  • [37] Development and Characterization of a Novel Single-Chain Antibody Against B-Cell Activating Factor
    Rasoul Mardani-Jouneghani
    Shiva Irani
    Mahdi Habibi-Anbouhi
    Mahdi Behdani
    Molecular Biotechnology, 2023, 65 : 1968 - 1978
  • [38] Hematopoietic stem cell transplantation in severe combined immunodeficiency patients: possible influence of donor age on recovery of B-cell function
    Schuetz, C
    Schulz, A
    Friedrich, W
    BONE MARROW TRANSPLANTATION, 2003, 31 : S45 - S45
  • [39] Evaluation of single and combined SYK- and BET inhibitor inhibition in canine and human B-cell lymphoid leukaemia cell lines
    Shu, X.
    Sender, S.
    Kong, W.
    Sekora, A.
    Packeiser, E. -M.
    Ruetgen, B.
    Nolte, I.
    Junghanss, C.
    Escobar, Murua H.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 65 - 65
  • [40] B-CELL FUNCTION IN SEVERE COMBINED IMMUNODEFICIENCY (SCID) FOLLOWING HLA-IDENTICAL AND HAPLOIDENTICAL MARROW TRANSPLANTATION
    BUCKLEY, RH
    SCHIFF, S
    JOHNSON, R
    BIGNER, S
    OCHS, HD
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (01) : 235 - 235